MarketBeat | Stock Market News & Analysis

Click here to learn how Larry builds trades and manages risk like a pro: https://marketbeat.com/y/larry This earnings week could bring big moves — and veteran trader Larry Benedict is here to break down how to trade it. In this video, Larry joins us to share real-world options strategies for two major companies reporting this week. You’ll learn: - How to trade earnings with defined risk using calls, puts, spreads, and iron condors - Why options aren’t as risky as people think — and how pros use them for smart exposure - What really matters this week: earnings results and forward guidance - Larry’s take on what makes PLTR and AMD stand out right now 🔔 Subscribe now to stay ahead of the market: https://marketbeat.link/youtube 📲 Text ’YouTube’ to 68285 for FREE SMS breaking news alerts on top stocks. 📈 Get MarketBeat All Access FREE for 30 Days: https://www.marketbeat.com/y/access #Palantir #AMD #OptionsTrading #EarningsSeason #StockMarket #Investing #MarketBeat #LarryBenedict #AIStocks #TechStocks #DefinedRisk #TradingStrategy DISCLAIMER: MarketBeat’s videos are for educational and informational purposes only and do not constitute financial, legal, or tax advice. We are not registered investment advisers, and nothing herein is a recommendation to buy, sell, or hold any security or strategy. Investing involves risk—including the potential loss of principal—so always perform your own due diligence and consult a licensed professional before acting. All opinions are those of the presenters and may change without notice. Presenters and MarketBeat personnel may own or trade the securities discussed. Past performance is not indicative of future results; any examples or case studies shown are illustrative and not typical. Some links or promotions mentioned may be affiliate partnerships that compensate MarketBeat at no additional cost to you. MarketBeat and its representatives accept no liability for any losses arising from reliance on this content.

How Dividend Investing Builds Real Wealth (Even in Volatile Markets) Some investors make thousands each month, just from dividends. It’s not a get-rich-quick scheme, but a time-tested strategy used by billionaires like Warren Buffett to generate passive income and build long-term wealth. In this video, we break down: ✅ What dividends are and how they work ✅ How to spot reliable dividend stocks (and avoid traps) ✅ The power of reinvesting for compounding growth ✅ Free MarketBeat tools that make dividend investing easier 📊 Whether you’re planning for retirement or looking to reduce risk, dividend investing can anchor your portfolio and generate steady income, no matter what the market’s doing. 🔗 Check out the tools featured in the video: Dividend Calculator: https://www.marketbeat.com/dividends/calculator/ Dividend Screener: https://www.marketbeat.com/dividends/screener/ Ex-Dividend Calendar: https://www.marketbeat.com/dividends/ex-dividend-calendar/ View All Stock Lists and Tools for Dividend Investors: https://www.marketbeat.com/dividends/ Read Automatic Income: https://www.automaticincomebook.com/ Like, subscribe, and comment below with your own dividend strategy. Thanks for watching and happy investing! 📲 Text ’YouTube’ to 68285 for FREE SMS breaking news alerts on top stocks. ✨ Get MarketBeat All Access FREE for 30 Days: 👉 https://www.marketbeat.com/subscribe/all-access/?utm_source=YouTube&RegistrationCode=YouTube

Congress Is Selling These 5 Stocks—Here’s What It Could Mean Both sides of the aisle, both chambers of Congress – lawmakers aren’t just buying stocks this summer. They’re selling… and in some cases, selling big. In this video Thomas Hughes breaks down the top 5 stocks members of Congress are selling the most right now – including one $3 million trade from a single member. From major names like to lesser-known companies flying under the radar, we explore what this selling spree might mean for investors. Are they taking profits? Dodging regulatory risk? Rebalancing around AI? We unpack the data and the potential motivations. 7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google: https://marketbeat.link/big Subscribe now to stay ahead of the market: https://marketbeat.link/youtube 📲 Text ’YouTube’ to 68285 for FREE SMS breaking news alerts on top stocks. ✨ Get MarketBeat All Access FREE for 30 Days: https://marketbeat.link/access #CongressionalTrading #StockMarketNews #InsiderTradingWatch #MicrosoftStock #GoogleStock #NvidiaStock #StockMarketAnalysis #MarketBeat #InvestingInsights #AIStocks #SemiconductorStocks #TradingTrends #InvestorWatch DISCLAIMER: MarketBeat’s videos are for educational and informational purposes only and do not constitute financial, legal, or tax advice. We are not registered investment advisers, and nothing herein is a recommendation to buy, sell, or hold any security or strategy. Investing involves risk—including the potential loss of principal—so always perform your own due diligence and consult a licensed professional before acting. All opinions are those of the presenters and may change without notice. Presenters and MarketBeat personnel may own or trade the securities discussed. Past performance is not indicative of future results; any examples or case studies shown are illustrative and not typical. Some links or promotions mentioned may be affiliate partnerships that compensate MarketBeat at no additional cost to you. MarketBeat and its representatives accept no liability for any losses arising from reliance on this content.

TSMC just delivered massive earnings growth—revenue up 40% year-over-year and EPS up 60%. But despite the blowout report, the stock dropped… again. In this video, MarketBeat’s Gabriel Ossorio-Mazilli breaks down why TSMC’s price action doesn’t match its fundamentals—and why he believes this could be one of the strongest buy-the-dip opportunities in the semiconductor space. With tariff tensions rising and volatility shaking the sector, TSMC may be uniquely positioned to lead the next chip cycle. Could it become the next great semiconductor giant? Or will global uncertainty continue to weigh it down? 📊 Download Your FREE Report: 7 Stocks That Will Still Be Magnificent in 2025 👉 marketbeat.link/magnificent 📲 Text ’YouTube’ to 68285 for FREE SMS breaking news alerts on top stocks. ✨ Get MarketBeat All Access FREE for 30 Days: 👉 https://www.marketbeat.com/subscribe/all-access/?utm_source=YouTube&RegistrationCode=YouTube #TSMC #Semiconductors #ChipStocks #TSMEarnings #StocksToBuy #GabrielOssorioMazilli #AIStocks #TechStocks #MarketVolatility #BuyTheDip #NVIDIA #Apple #Tariffs #InvestingTips #MarketBeat

A $2.5 billion merger is reshaping the gold industry — and most investors aren’t paying attention. Equinox Gold just completed its acquisition of Calibre Mining, creating one of North America’s largest gold producers. With two new Canadian mines ramping up production and gold trading near all-time highs, this could be a massive opportunity. We talk with gold expert Ryan King from Equinox Gold about: -Why central banks are loading up on gold -How Equinox plans to produce 1M+ ounces annually -The $1.3B cash flow outlook and what’s next for shareholders -What this means for gold stocks vs. physical gold -And why this quiet merger could lead to a major re-rating Check out Equinox Gold (NYSE-A: EQX)) to learn more about their rapidly growing North American gold production here: https://tomorrowinvestor.com/equinox-gold-positioned-for-top-tier-gold-status- yet-still-valued/. Take a look at the company website here: https://www.equinoxgold.com. Disclosure/Disclaimer: We are not securities dealers or brokers, investment advisers or financial advisers, and you should not rely on the information herein as investment advice. Any investment should be made only after consulting a professional investment advisor and only after reviewing the financial statements and other pertinent corporate information. Further, readers are advised to read and carefully consider the Risk Factors identified and discussed in the profiled company’s SEC and/or other government filings. Investing in securities, particularly microcap securities, is speculative and carries a high degree of risk. This video was conducted on behalf of Equinox Gold, and was funded by Think Ink Marketing. For our full disclaimer, please visit: https://tomorrowinvestor.com/equinox-gold-positioned-for-top-tier-gold-status-yet-still-valued/#disclaimer #GoldStocks #EquinoxGold #GoldInvesting #StockMarketNews #InvestingTips #MergerNews #GoldBullRun #SafeHavenAssets #MarketBeat #StocksToBuy #StockPicks #InvestingVideos #AIStocks #EconomicOutlook #GeopoliticsAndGold Subscribe now to stay ahead of the market: https://marketbeat.link/youtube Text ’YouTube’ to 68285 for FREE SMS breaking news alerts on top stocks. Get MarketBeat All Access FREE for 30 Days: https://marketbeat.link/access DISCLAIMER: MarketBeat’s videos are for educational and informational purposes only and do not constitute financial, legal, or tax advice. We are not registered investment advisers, and nothing herein is a recommendation to buy, sell, or hold any security or strategy. Investing involves risk—including the potential loss of principal—so always perform your own due diligence and consult a licensed professional before acting. All opinions are those of the presenters and may change without notice. Presenters and MarketBeat personnel may own or trade the securities discussed. Past performance is not indicative of future results; any examples or case studies shown are illustrative and not typical. Some links or promotions mentioned may be affiliate partnerships that compensate MarketBeat at no additional cost to you. MarketBeat and its representatives accept no liability for any losses arising from reliance on this content.

The major U.S. indexes are sitting at all-time highs… But with stocks trading at such steep premiums—is there still value to be found? 📈 Get the FREE List of the Top 5 AI & Autonomy Stocks trading under $15 with massive potential growth: https://www.marketbeat.com/y/autonomy MarketBeat’s Gabriel Osorio-Mazilli shares 3 overlooked value plays that Wall Street analysts believe could rise as much as 47% from current levels. These aren’t your typical momentum stocks—they’ve underperformed, but analysts are doubling down. Is this your opportunity to get in before the crowd? Or are these stocks cheap for a reason? 🔔 Subscribe now to stay ahead of the market: https://marketbeat.link/youtube 📲 Text ’YouTube’ to 68285 for FREE SMS breaking news alerts on top stocks. 📈 Get MarketBeat All Access FREE for 30 Days: https://www.marketbeat.com/y/access #StocksToBuy #stockpicks #investingtips #investingvideos #undervaluedstocks #WallStreet #valueinvesting #topstocks2025 #MarketBeat #GabrielOssorioMassili #stockmarketnews DISCLAIMER: MarketBeat’s videos are for educational and informational purposes only and do not constitute financial, legal, or tax advice. We are not registered investment advisers, and nothing herein is a recommendation to buy, sell, or hold any security or strategy. Investing involves risk—including the potential loss of principal—so always perform your own due diligence and consult a licensed professional before acting. All opinions are those of the presenters and may change without notice. Presenters and MarketBeat personnel may own or trade the securities discussed. Past performance is not indicative of future results; any examples or case studies shown are illustrative and not typical. Some links or promotions mentioned may be affiliate partnerships that compensate MarketBeat at no additional cost to you. MarketBeat and its representatives accept no liability for any losses arising from reliance on this content.

5 Strong Buy Stocks for August: Momentum, Value & Takeover Potential Are we entering a hypergrowth era for select stocks? MarketBeat’s Thomas Hughes breaks down five standout picks for August—including momentum plays projected to deliver triple-digit growth, undervalued companies near critical support levels, and stocks that could be prime takeover targets. From fast-moving growth stocks to pullbacks on fundamentally strong names, this diverse group has something for every investor. Whether you’re chasing upside or looking for a smart entry point, these ideas are worth a spot on your radar. Will these 5 stocks make your August buy list? Get the full breakdown and the reasoning behind each pick—backed by data, technical levels, and real market trends. Looking for dividend stocks instead? Don’t miss our free premium article: Top 5 Undervalued Dividend Stocks With Strong Payout Potential https://marketbeat.com/y/dividend 🔔 Subscribe now to stay ahead of the market: https://marketbeat.link/youtube 📲 Text ’YouTube’ to 68285 for FREE SMS breaking news alerts on top stocks. 📈 Get MarketBeat All Access FREE for 30 Days: https://www.marketbeat.com/y/access #StrongBuyStocks #StockMarket #GrowthStocks #ValueInvesting #AugustStockPicks #Investing #MarketBeat #ThomasHughes #StockAnalysis #DividendStocks DISCLAIMER: MarketBeat’s videos are for educational and informational purposes only and do not constitute financial, legal, or tax advice. We are not registered investment advisers, and nothing herein is a recommendation to buy, sell, or hold any security or strategy. Investing involves risk—including the potential loss of principal—so always perform your own due diligence and consult a licensed professional before acting. All opinions are those of the presenters and may change without notice. Presenters and MarketBeat personnel may own or trade the securities discussed. Past performance is not indicative of future results; any examples or case studies shown are illustrative and not typical. Some links or promotions mentioned may be affiliate partnerships that compensate MarketBeat at no additional cost to you. MarketBeat and its representatives accept no liability for any losses arising from reliance on this content.

Think mega-cap stocks are too big to be exciting? Think again. Get FREE Options Training from Nate Tucci: https://marketbeat.link/nate These 3 “boring” giants—Apple, Progressive, and Tesla—have crushed the S&P 500 and continue delivering daily profit potential for short-term traders and long-term investors alike. Nate Tucci from Prosperity Pub breaks down how he turns these familiar names into pure profit machines. Subscribe now to stay ahead of the market: https://marketbeat.link/youtube 📲 Text ’YouTube’ to 68285 for FREE SMS breaking news alerts on top stocks. ✨ Get MarketBeat All Access FREE for 30 Days: https://marketbeat.link/access DISCLAIMER: MarketBeat’s videos are for educational and informational purposes only and do not constitute financial, legal, or tax advice. We are not registered investment advisers, and nothing herein is a recommendation to buy, sell, or hold any security or strategy. Investing involves risk—including the potential loss of principal—so always perform your own due diligence and consult a licensed professional before acting. All opinions are those of the presenters and may change without notice. Presenters and MarketBeat personnel may own or trade the securities discussed. Past performance is not indicative of future results; any examples or case studies shown are illustrative and not typical. Some links or promotions mentioned may be affiliate partnerships that compensate MarketBeat at no additional cost to you. MarketBeat and its representatives accept no liability for any losses arising from reliance on this content. #StocksToBuy #stockpicks #investingtips #investingvideos #Apple #Tesla #Progressive #MegaCapStocks #ShortTermTrading #OptionsTrading #ValueStocks #StockMarketStrategy #PureProfitTrades

The eVTOL Race Is Heating Up: Joby vs. Archer — Who Comes Out Ahead? Joby Aviation has nearly doubled in the last month. Archer Aviation is up 25%. These are the two biggest names in the electric vertical takeoff and landing (eVTOL) space — and both are gaining serious altitude. But what actually sets them apart? MarketBeat analyst Jeffrey Neal Johnson, who’s been tracking this industry for two years, breaks down the latest developments, key differentiators, and where each company stands in the race to transform transportation as we know it. In this video: -Why Joby and Archer are both gaining traction — and where their strategies diverge -How hydrogen fuel cells are changing the game for one key player -Who’s positioned to scale faster, win contracts, and dominate the skies Plus: Stick around to the end for Jeffrey’s picks on under-the-radar eVTOL stocks that could soon catch up — or even pass — the current frontrunners. Subscribe now to stay ahead of the market: https://marketbeat.link/youtube Text ’YouTube’ to 68285 for FREE SMS breaking news alerts on top stocks. Get MarketBeat All Access FREE for 30 Days: https://marketbeat.link/access DISCLAIMER: MarketBeat’s videos are for educational and informational purposes only and do not constitute financial, legal, or tax advice. We are not registered investment advisers, and nothing herein is a recommendation to buy, sell, or hold any security or strategy. Investing involves risk—including the potential loss of principal—so always perform your own due diligence and consult a licensed professional before acting. All opinions are those of the presenters and may change without notice. Presenters and MarketBeat personnel may own or trade the securities discussed. Past performance is not indicative of future results; any examples or case studies shown are illustrative and not typical. Some links or promotions mentioned may be affiliate partnerships that compensate MarketBeat at no additional cost to you. MarketBeat and its representatives accept no liability for any losses arising from reliance on this content.

It’s one of the most explosive sectors in the market — but also one of the riskiest. Biotech investors, beware. Small-cap biotech stocks can be extremely volatile… but if you know what to look for, the payoff can be massive. In this video, MarketBeat contributor Chris Markoch breaks down 3 small-cap biotech stocks with major FDA catalysts in motion — including clinical trial breakthroughs, fast track designations, and upcoming approvals that could trigger major moves. One stock could see gains of over 117% from where it’s trading today. Another is working in the red-hot gene editing space — a segment set for explosive growth. If you’re looking for biotech opportunities with high risk and high reward potential, this is the list to watch. Click here for the exclusive article 5 High-Risk, High-Reward Stocks With Serious Momentum: https://marketbeat.link/momentum Explore MarketBeat’s FDA tools here: https://www.marketbeat.com/fda-events/ Subscribe now to stay ahead of the market: https://marketbeat.link/youtube Text ’YouTube’ to 68285 for FREE SMS breaking news alerts on top stocks. Get MarketBeat All Access FREE for 30 Days: https://marketbeat.link/access #BiotechStocks #SmallCapBiotech #FDAApproval #GeneEditing #ClinicalTrials #Investing #StockMarket #GrowthStocks #HighRiskHighReward #StocksToWatch #MarketBeat #StockAnalysis #ExplosiveStocks #StockNews #BiotechInvesting #marketbeat DISCLAIMER: MarketBeat’s videos are for educational and informational purposes only and do not constitute financial, legal, or tax advice. We are not registered investment advisers, and nothing herein is a recommendation to buy, sell, or hold any security or strategy. Investing involves risk—including the potential loss of principal—so always perform your own due diligence and consult a licensed professional before acting. All opinions are those of the presenters and may change without notice. Presenters and MarketBeat personnel may own or trade the securities discussed. Past performance is not indicative of future results; any examples or case studies shown are illustrative and not typical. Some links or promotions mentioned may be affiliate partnerships that compensate MarketBeat at no additional cost to you. MarketBeat and its representatives accept no liability for any losses arising from reliance on this content.